Objective:To evaluate the effect of captopril combined with coenzyme Q10 on cardiac injury after acute carbon monoxide poisoning. Methods:Two hundred patients of cardiac injury after acute CO poisoning were enrolled in this study. All the patients were randomly and equally divided into control group treated with captopril and experimental group treated with captopril combined coenzyme Q10. The course of treatment was 12 weeks. After treatment for 6 and 12 weeks, echocardiography was conducted on all the patients and the levels of high sensitive C reactive protein(hs-CRP), pro-brain natriuretic peptide(pro-BNP), CK-MB(cTnI)and cardiac troponin I were determined. Results:After 6 weeks'treatment, CK-MB levels of the experimental group were significantly lower than those of the control group(P=0.002). After 12 weeks of treatment, the levels of LVEDd and LVESD in experimental group were significantly lower than those in the control group, while that of LVEF was significantly higher(P=0.001). The pro-BNP, cTnI and CRP levels in the experimental group was significantly lower than those of the control group(P=0.001, 0.002, 0.001)after 12 weeks of treatment. Conclusion:Combined use of captopril and coenzyme Q10 capsules can effectively inhibit the malignant remodeling of the heart and hypoxia-induced myocardial damage, and improve the left ventricular systolic function in patients with myocardial injury caused by acute CO poisoning. |
[1] JIANG J,CHAN A,ALI S,et al.Hydrogen Sulfide-mechanisms of toxicity and development of an antidote[J].Sci Rep,2016,15(6):20831.
[2] HANS-DIRK D,SVETLANA A.Titration to target dose of bisoprolol vs carvedilol in elderly patients with heart failure:the CIBIS-ELD trial[J].Eur J Heart Fail,2011,13(6):670-680.
[3] MUTLUOGLU M,METIN S,IBRAHIM-ARZIMA N,et al.The use of hyperbaric oxygen therapy for carbon monoxide poisoning in Europe[J].Undersea Hyperb Med,2016,43(1):49-56.
[4] HAMPSON N B,WEAVER L K.Carbon monoxide poisoning and risk for venous thromboembolism[J].J Epidemiol Community Health,2016,22(3):207172.
[5] CHRISTIAN S,DIRK W,STEFAN B,et al.Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction[J].World J Cardiol,2015,7(12):843-860.
[6] BENMOSTEFA N,BOUSSEKINE F Z,KHABBAT H,et al.P-114:Stroke and ischemic heart disease,therefore poisoning carbon monoxide[J].Ann Cardiol Angeiol(Paris),2015,64(Suppl 1):S61-S62.
[7] MASHAYEKHIAN M,HASSANIAN M H,RAHIMI M,et al.Elevated carboxyhemoglobin concentrations by pulse CO-oximetry is associated with severe aluminium phosphide poisoning[J].Basic Clin Pharmacol Toxicol,2016,119(3):322-329.
[8] BRITT F,THOMAS S H,JAKOB R,et al.Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study[J].Cardiovasc Diabetol,2011,10:91.
[9] BURLAKA A P,GANUSEVICH I,GOLOTIUK W,et al.Superoxide-and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10[J].Exp Oncol,2016,38(1):31-35.
[10] BEHIN A,ACQUAVIVA C,SOUVANNANORATH S,et al.Multiple acyl-CoA dehydrogenase deficiency(MADD)as a cause of late-onset treatable metabolic disease[J].Rev Neurol(Paris),2016,172(3):231-241.
[11] SHARMA A,FONAROW G C,BUTLER J,et al.Coenzyme Q10 and heart failure:a state-of-the-art review[J].Circ Heart Fail,2016,9(4):e002639.
[12] AKINYEMI O,DAVID L.Pharmacogenomics in heart failure:where are we now and how can we reach clinical application[J].Cardiol Rev,2014,22(5):193-198.
[13] DRINHAUS H,NüSGEN S,HINKELBEIN J.Guidelines desirable for treatment of carbon monoxide poisoning[J].Anaesthesist,2016,65(4):301-302.
[14] VALERIO Z,SHARADH R,SUDHISH M,et al.Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure[J].Cardiology,2009,112(4):294-302.
[15] SHI M Y,HUA J.Insights into the monomers and single drugs of chinese herbal medicine on myocardial preservation[J].Afr J Tradit Complement Altern Med,2011,8(2):104-127. |